Cipher Pharmaceuticals

Cipher Pharmaceuticals is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products.

[Cipher Pharmaceuticals @CipherPharmaIR]

@CipherPharmaIR $CPH $CPHRF has released its Q2 2024 Earnings Release today at market close. The conference call to discuss the report and recent company developments will take place tomorrow @ 8:30 a.m. EST.

Read the report here: https://t.co/i34DDodnzM

#investing #pharma

[Cipher Pharmaceuticals @CipherPharmaIR]

@CipherPharmaIR $CPH $CPHRF is pleased to announce that it will release its Q2 2024 financial results next Thursday, August 8th.

To discuss the report & recent milestones, there will be an earnings call August 9th @ 8:30 a.m. ET.

View the webcast here: https://t.co/2pftdugd5l

[Cipher Pharmaceuticals @CipherPharmaIR]

@CipherPharmaIR $CPH announces the signing & closing of an agreement to acquire the global rights to Natroba (Spinosad) from ParaPRO LLC, immediately doubling $CPHRF's revenue & earnings as we expand our North American #dermatology footprint.

Read more: https://t.co/aCKlbFHM8e

[Cipher Pharmaceuticals @CipherPharmaIR]

@CipherPharmaIR $CPH $CPHRF is proud to announce it has released its Q1 2024 financial results. Highlights include a 20% increase in Q1 2024 revenue and a total gross profit increase of 23.1% compared to Q1 2023.

Read the release here: https://t.co/JWccjileip

[Cipher Pharmaceuticals @CipherPharmaIR]

@CipherPharmaIR $CPH will release its Q1 earnings after market close on Thursday, May 9, followed by a conference call on Friday, May 10, 2024, at 8:30 AM ET to discuss the results and recent corporate developments.

To register for the call, click here: https://t.co/jBdHJJTmd8

[Cipher Pharmaceuticals @CipherPharmaIR]

In April, @CipherPharmaIR $CPH seized the spotlight at the Bloom Burton Conference. The presentation highlighted our prominent position as a fast-growing specialty #pharma focused on bringing to market high-quality products that advance science and improve lives.

[Cipher Pharmaceuticals @CipherPharmaIR]

@CipherPharmaIR $CPH is excited to announce we will be presenting at the @BloomBurton Healthcare Investor Conference on April 17th @ 2:30 p.m. EST. Join us to learn more about our strategy to become the dominant force in specialty #pharma.

Register here: https://t.co/lKDGhsmfQk

[Cipher Pharmaceuticals @CipherPharmaIR]

🔊 Cipher's $CPH $CPHRF 2023 Q4 & Full Year earnings call transcript is now available! 🔊

To read about @CipherPharmaIR's exciting developments of last year, click here: https://t.co/bErdAksR9h

[Cipher Pharmaceuticals @CipherPharmaIR]

@CipherPharmaIR $CPH $CPHRF is proud to celebrate its 20th year on the #TSX! We’d like to thank our team and shareholders who have made this possible.

#Cipher looks forward to new significant milestones as we continue to build Canada's leading specialty #pharma company.

[Cipher Pharmaceuticals @CipherPharmaIR]

@CipherPharmaIR $CPH today announced its financial and operating results for the year of 2023. Join our conference call discussing the report tomorrow @ 8:30 am ET - to access the conference call by telephone, dial [phone].

Read the release here: https://t.co/XYb8aBkht7

[Cipher Pharmaceuticals @CipherPharmaIR]

Meet the #CipherTeam

@CipherPharmaIR's CFO, Bryan Jacobs, holds decades of experience in Canadian and U.S. capital markets & strategic M&A. We're eager for Bryan to guide our infrastructure-light portfolio management & commercialization.

Learn more: https://t.co/KCojzAAXvc

[Cipher Pharmaceuticals @CipherPharmaIR]

@CipherPharmaIR $CPH will release its Q4 & its 2023 full year financial results after market close on Thursday, March 14 as well as hold our earnings call on Friday, March 15 at 8:30 ET to discuss the results & corporate developments.

Read the release: https://t.co/FCLWmJHEHp

[Cipher Pharmaceuticals @CipherPharmaIR]

Meet the #CipherTeam

Craig Mull, our interim CEO, comes to us after taking a #pharma company from $20m in revenue to over $235m & guiding it through it's public launches. With his experience, Craig provides a reliable anchor for our team.

Learn more: https://t.co/KCojzAAXvc

[Cipher Pharmaceuticals @CipherPharmaIR]

@CipherPharmaIR $CPHRF offers an exciting value proposition for investors searching for a #pharma company that is established across the Americas, has a strong balance sheet, and convincing growth at 33% CAGR since 2020.

See our investor presentation: https://t.co/AlqziyQfEv

[Cipher Pharmaceuticals @CipherPharmaIR]

Tattoo removal is known to be more painful than the tattoo itself. That's why @CipherPharmaIR $CPH is working on a topical, non-invasive tattoo removal treatment.

In the meantime, read this article and think twice before getting a tattoo you may regret: https://t.co/vtbxxaCzi5

[Cipher Pharmaceuticals @CipherPharmaIR]

Cipher Pharmaceuticals $CPH $CPHRF)was mentioned on BNN (Canada’s CNBC) today as a top pick by Stifel Institutional Justin Keywood..

https://t.co/ikn6nvSzyC

#cipher #smallcap #pickoftheday

[Cipher Pharmaceuticals @CipherPharmaIR]

Investing in @CipherPharmaIR $CPH $CPHRF offers a unique opportunity to invest in an established #pharma company with a history of positive operating cash flow and a robust pipeline of innovative products.

Learn about Cipher's exciting value proposition: https://t.co/YIR0jiK2Dv

[Cipher Pharmaceuticals @CipherPharmaIR]

@CipherPharmaIR $CPH $CPHRF continues to develop best-in-class products for unmet medical needs. Our #ConZip offers around-the-clock #treatment for adults with moderate #chronicpain.

To read about our innovative array of products, click here: https://t.co/0WnaSVfsxs

#pharma

[Cipher Pharmaceuticals @CipherPharmaIR]

Cipher (TSX: CPH) (OTCQX: CPHRF) is proud to announce that its common shares are now trading on the OTCQX® Best Market!

To learn more about the listing, click here: https://t.co/IperjGI1mw

#Cipher #pharma #healthcare #OTCQX #smallcaps